Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management

por Rapoport, Bernardo L.
Publicado 2017

Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

por Anderson, Ronald, Rapoport, Bernardo L.
Publicado 2018

Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy

por Rapoport, Bernardo L., Anderson, Ronald
Publicado 2019

Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells

por Anderson, Ronald, Theron, Annette J., Rapoport, Bernardo L.
Publicado 2019

Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review

por van Eeden, Ronwyn, Rapoport, Bernardo L., Smit, Teresa, Anderson, Ronald
Publicado 2019

Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer

por Anderson, Ronald, Rapoport, Bernardo L., Steel, Helen C., Theron, Annette J.
Publicado 2023

Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer

por Theron, Annette J., Steel, Helen C., Rapoport, Bernardo L., Anderson, Ronald
Publicado 2020

Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy

por Navari, Rudolph M., Rapoport, Bernardo L., Powers, Dan, Arora, Sujata, Clark‐Snow, Rebecca
Publicado 2018

Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy†

por Rapoport, Bernardo L., Steel, Helen C., Theron, Annette J., Smit, Teresa, Anderson, Ronald
Publicado 2020

A South African Breast Implant-Associated Anaplastic Large Cell Lymphoma: Clinical Presentation and Six-Year Follow-Up

por Grubnik, Alexandra, Ramdas, Yastira, Van der Bergh, Barend, Nayler, Simon, Benn, Carol-Ann, Rapoport, Bernardo L.
Publicado 2022

High Mobility Group Box 1 in Human Cancer

por Rapoport, Bernardo L., Steel, Helen C., Theron, Annette J., Heyman, Liezl, Smit, Teresa, Ramdas, Yastira, Anderson, Ronald
Publicado 2020

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

por Kuehr, Thomas, Ruff, Paul, Rapoport, Bernardo L, Falk, Stephen, Daniel, Francis, Jacobs, Conrad, Davidson, Neville, Thaler, Josef, Boussard, Blandine, Carmichael, James
Publicado 2004

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from...

por Weinstein, Cindy, Jordan, Karin, Green, Stuart, Khanani, Saleem, Beckford-Brathwaite, Elizabeth, Vallejos, Waldimir, Pong, Annpey, Noga, Stephen J., Rapoport, Bernardo L.
Publicado 2020

Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Gro...

por Rapoport, Bernardo L., Shannon, Vickie R., Cooksley, Tim, Johnson, Douglas B., Anderson, Lindsay, Blidner, Ada G., Tintinger, Gregory R., Anderson, Ronald
Publicado 2021

Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences

por Santoni, Matteo, Molina-Cerrillo, Javier, Santoni, Giorgio, Lam, Elaine T., Massari, Francesco, Mollica, Veronica, Mazzaschi, Giulia, Rapoport, Bernardo L., Grande, Enrique, Buti, Sebastiano
Publicado 2023

Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a...

por Kgokolo, Mahlatse C. M., Anderson, Katherine, Siwele, Shalate C., Steel, Helen C., Kwofie, Luyanda L. I., Sathekge, Mike M., Meyer, Pieter W. A., Rapoport, Bernardo L., Anderson, Ronald
Publicado 2022

Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma

por Malinga, Nonkululeko Z., Siwele, Shalete C., Steel, Helen C., Kwofie, Luyanda L.I., Meyer, Pieter W.A., Smit, Teresa, Anderson, Ronald, Rapoport, Bernardo L., Kgokolo, Mahlatse C.M.
Publicado 2022

Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma: Results of the South African Expanded-Access Program

por Rapoport, Bernardo L., Vorobiof, Daniel A., Dreosti, Lydia M., Nosworthy, Adam, McAdam, Georgina, Jordaan, Johan P., Miller-Jansön, Helen, de Necker, Margreet, de Beer, Janetta C., Duvenhage, Hennie
Publicado 2016

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD...

por Rapoport, Bernardo L., Steel, Helen C., Benn, Carol A., Nayler, Simon, Smit, Teresa, Heyman, Liezl, Theron, Annette J., Hlatshwayo, Nomsa, Kwofie, Luyanda L.I., Meyer, Pieter W.A., Anderson, Ronald
Publicado 2023

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules

por Rapoport, Bernardo L., Steel, Helen C., Hlatshwayo, Nomsa, Theron, Annette J., Meyer, Pieter W. A., Nayler, Simon, Benn, Carol-Ann, Smit, Teresa, Kwofie, Luyanda L. I., Heyman, Liezl, Anderson, Ronald
Publicado 2022